We report a case of a 25-day old, former 34-week gestation male newborn who experienced neonatal seizures following administration of subcutaneous lidocaine for regional anesthesia during an elective circumcision prior to discharge.
INTRODUCTION

Lidocaine (Xylocaine
is an amide-type anesthetic widely used in newborns to provide local anesthesia (nerve block) during circumcision. Neonatal seizures following recommended doses of lidocaine have been minimally reported.
We report a case of neonatal seizures in a 25-day old, former 34-week male newborn, following lidocaine administration for an elective circumcision.
CASE REPORT
A 2514 g male infant was born at 33 and 6/7 weeks gestation to a 28-year-old gravida three para one woman who had a pregnancy complicated by mild pregnancy-induced hypertension. Her blood type was A positive, antibody negative, rubella immune, Hepatitis B surface antigen negative, RPR nonreactive, with an unknown Group B Streptococcus status. She presented at a community hospital in preterm labor, with rupture of membranes 5 hours prior to delivery. She did not receive steroids or tocolysis and received one dose of antibiotics. The infant was born by vaginal delivery with APGARs of 6 and 8 at 1 and 5 minutes, respectively. He went on to develop nasal flaring, grunting and retractions soon after birth and was transferred to our NICU.
His hospital course was complicated by transient hypotension as well as respiratory distress syndrome requiring mechanical ventilation and one dose of surfactant. He was extubated onto nasal CPAP on day of life 2. His sepsis evaluation was negative. Antibiotics were continued for 7 days for possible pneumonia. On day of life 25, an elective circumcision with subcutaneous lidocaine for regional anesthesia was performed on the day of planned discharge.
The mother of our patient noted a very short episode of new onset extremity and facial twitching within 10 minutes of the circumcision, but did not report her observations until further abnormal movements occurred. Approximately 30 minutes after the procedure, the newborn exhibited evidence of a generalized tonic clonic seizure. Subsequently, a second self-resolving generalized seizure occurred. A CBC, electrolytes, electroencephalography (EEG) and head computed tomography (CT) were all within normal limits. Both the lidocaine dose and route of administration were verified and within the recommended range. A lidocaine level of 0.7 mg/ml was measured approximately 6 hours after the second reported tonic clonic seizure. No further seizures were noted and the newborn was discharged on day of life 27 on multivitamins, ferrous sulfate drops and no antiseizure medications. Neurology follow-up through 6 months of age has been within normal limits.
DISCUSSION
NICU graduates and newborn male infants may have circumcision routinely performed using subcutaneous lidocaine for local anesthesia. Many of these procedures are done just prior to discharge home. Neonatal seizures following recommended doses of lidocaine administered for local anesthesia for this extremely common procedure have not been reported to the best of our knowledge.
We report a case of tonic-clonic seizures in a 25-day-old former premature newborn following elective circumcision with a quantified lidocaine level of 0.7 mg/ml. Based on the timing of the tonic-clonic seizures in our patient, lidocaine appeared to be the most likely cause of these seizures. The clinical presentation was not consistent with a hypersensitivity reaction.
Lidocaine-induced seizures have been reported in infants, children, and adults. [1] [2] [3] [4] In adults, serum concentrations more than 5 mg/ml lower the seizure threshold in the cerebral cortex, amygdala, and hippocampus, usually causing a generalized convulsion. 2 In children receiving continuous infusions of lidocaine, adverse effects have been reported at levels ranging from 1.8 to 4.7 mg/ml.
5
Seizures have been previously reported in a neonate where intravenous lidocaine was given in conjunction with midazolam and atropine for preoperative intubation. 1 The serum level in this patient was only 0.3 mg/ml; and the seizures resolved with diazepam.
Delayed maturation of drug metabolizing enzymes may predispose premature and term neonates to adverse effects from drugs such as lidocaine. 6 Lidocaine undergoes extensive hepatic metabolism via the cytochrome P450 isoforms 3A4 and 1A2 to form monoethylglycinexylide (MEGX) and glycinexylide (GX). MEGX and GX are two active but less potent metabolites of the parent compound. 7 Neither 3A4 nor 1A2 are expressed in the fetal liver. [8] [9] [10] [11] CYP 3A7 is the predominant isoform expressed in the fetal liver. The expression or activity of 3A7 peaks shortly after birth and then declines as it is replaced by 3A4. By 1 month of age, 3A4 activity is approximately 30% to 40% of adults and continues to increase throughout the first few months of life.
9-11 CYP 1A2 is the last major isoform to develop and is barely detectable in the neonatal period. Its expression occurs between 1 and 3 months of age and reaches 50% of adult values around 12 months of age. 8 Prolonged elimination half-life, increased volume of distribution and decreased protein binding may also predispose premature neonates to adverse effects. Lidocaine is approximately 20% protein bound in neonates compared to 80% in adults. This decrease in protein binding increases the amount of unbound and active drug. 1 Our case report raises the following important questions: (1) are premature newborns more likely to exhibit adverse effects to recommended doses of lidocaine secondary to immature hepatic function and increased drug bioavailability; (2) should lower doses of lidocaine or other anesthetics altogether be used in premature newborns undergoing circumcision; and (3) should there be a longer observation period prior to discharge for premature neonates after circumcision?
Until further studies are available, we now recommend that former premature newborns undergoing elective circumcisions and other procedures using local anesthetics be performed at least 24 hours prior to planned discharge.
